The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
New frontiers in nanotechnology for cancer treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198
Self-citationBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Self-citationSearching for Peptide Ligands with an Epitope Library
Scott, J. K., & Smith, G. P. (1990) · Science · doi:10.1126/science.1696028 · Cited by 2,084
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778
Self-citationGref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Self-citationAdaptive Recognition by Nucleic Acid Aptamers
Hermann, T., & Patel, D. J. (2000) · Science · doi:10.1126/science.287.5454.820 · Cited by 1,650
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Wang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Small-scale systems for in vivo drug delivery
LaVan, D. A., McGuire, T., & Langer, R. (2003) · Nature Biotechnology · doi:10.1038/nbt876 · Cited by 1,304
Self-citationFormulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Self-citationMultifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
In Vitro Selection of Functional Nucleic Acids
Wilson, D. S., & Szostak, J. W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.611 · Cited by 1,206
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Self-citationKirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Advances in biomaterials, drug delivery, and bionanotechnology
Langer, R., & Peppas, N. A. (2003) · AIChE Journal · doi:10.1002/aic.690491202 · Cited by 966
Self-citationAptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Self-citationRoss, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
Savill, J., Dransfield, I., Hogg, N., & Haslett, C. (1990) · Nature · doi:10.1038/343170a0 · Cited by 846
The 'right' size in nanobiotechnology
Whitesides, G. M. (2003) · Nature Biotechnology · doi:10.1038/nbt872 · Cited by 843
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Self-citationDelivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Antibody targeted drugs as cancer therapeutics
Schrama, D., Reisfeld, R. A., & Becker, J. C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1957 · Cited by 768
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Responsive polymeric delivery systems
Kost, J., & Langer, R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00136-8 · Cited by 747
Self-citationαv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2000) · PubMed · Cited by 633
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
Self-citationPolymer Architecture and Drug Delivery
Qiu, L. Y., & Bae, Y. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9046-2 · Cited by 604
Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm0506142 · Cited by 596
Langer, R. (2001) · Science · doi:10.1126/science.1063273 · Cited by 579
Self-citationStimuli-Responsive Supramolecular Assemblies of Linear-Dendritic Copolymers
Gillies, E. R., Jonsson, T. B., & Fréchet, J. M. J. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0463738 · Cited by 549
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
Padilla De Jesús, O. L., Ihre, H. R., Gagne, L., Fréchet, J. M. J., & Szoka, F. C. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010103m · Cited by 507
Hirsch, L. R., Gobin, A. M., Lowery, A. R., Tam, F., Drezek, R. A., Halas, N. J., & West, J. L. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9001-8 · Cited by 497
Controlled assembly of dendrimer-like DNA
Li, Y., Tseng, Y. D., Kwon, S. Y., d'Espaux, L., Bunch, J. S., McEuen, P. L., & Luo, D. (2004) · Nature Materials · doi:10.1038/nmat1045 · Cited by 482
Water-soluble dendritic unimolecular micelles:
Liu, M., Kono, K., & Fréchet, J. M. J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00245-x · Cited by 477
Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., & Zalipsky, S. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9801124 · Cited by 468
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Bae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445
Human antibodies from transgenic animals.
Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434
Yin, X., Hoffman, A. S., & Stayton, P. S. (2006) · Biomacromolecules · doi:10.1021/bm0507812 · Cited by 416
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Self-citationGopinath, S. C. B. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0826-2 · Cited by 392
Efficient Cancer Therapy with a Nanobody-Based Conjugate
Cortez-Retamozo, V., Backmann, N., Senter, P. D., Wernery, U., De Baetselier, P., Muyldermans, S., & Revets, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3935 · Cited by 382
Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement
Gupta, U., Agashe, H. B., Asthana, A., & Jain, N. K. (2006) · Biomacromolecules · doi:10.1021/bm050802s · Cited by 375
Receptor-mediated folate accumulation is regulated by the cellular folate content.
Kamen, B. A., & Capdevila, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5983 · Cited by 350
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Roovers, R. C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A. J., Revets, H., de Haard, H. J., & van Bergen en Henegouwen, P. M. P. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0180-4 · Cited by 346
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Gillies, E. R., & Fréchet, J. M. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja028100n · Cited by 328
Perez, C., Sanchez, A., Putnam, D., Ting, D., Langer, R., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00397-2 · Cited by 313
Self-citationPotent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
Kim, E. S., Serur, A., Huang, J., Manley, C. A., McCrudden, K. W., Frischer, J. S., Soffer, S. Z., Ring, L., New, T., Zabski, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398399 · Cited by 312
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
Schiffelers, R. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00240-2 · Cited by 310
(2024) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-031-52864-4 · Cited by 309
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizón, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., & Zalipsky, S. (2003) · PubMed · Cited by 295
Aptamer:Toxin Conjugates that Specifically Target Prostate Tumor Cells
Chu, T. C., Marks, J. W., Lavery, L. A., Faulkner, S., Rosenblum, M. G., Ellington, A. D., & Levy, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4583 · Cited by 284
A Theoretical Model for the Margination of Particles within Blood Vessels
Decuzzi, P., Lee, S., Bhushan, B., & Ferrari, M. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8976-5 · Cited by 280
Gillies, E. R., Dy, E., Fréchet, J. M. J., & Szoka, F. C. (2005) · Molecular Pharmaceutics · doi:10.1021/mp049886u · Cited by 265
Park, E. K., Lee, S. B., & Lee, Y. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.008 · Cited by 264
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Self-citationEngineering of therapeutic antibodies to minimize immunogenicity and optimize function
Presta, L. G. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.026 · Cited by 246
Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates
Sharkey, R. M., & Goldenberg, D. M. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.4.226 · Cited by 242
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains
Silverman, J., Lu, Q., Bakker, A., To, W., Duguay, A., Alba, B. M., Smith, R., Rivas, A., Li, P., Le, H., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1166 · Cited by 237
Slepushkin, V. A., Simões, S., Dazin, P., Newman, M. S., Guo, L. S., de Lima, M. C. P., & Düzgüneş, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2382 · Cited by 235
Khaled, A., Guo, S., Li, F., & Guo, P. (2005) · Nano Letters · doi:10.1021/nl051264s · Cited by 233
Eskens, F. A. L. M., Dumez, H., Hoekstra, R., Perschl, A., Brindley, C., Böttcher, S., Wynendaele, W., Drevs, J., Verweij, J., & van Oosterom, A. T. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00057-1 · Cited by 225
Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells
Steinhauser, I., Spänkuch, B., Strebhardt, K., & Langer, K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.016 · Cited by 216
Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries
Krag, D. N., Shukla, G. S., Shen, G.-P., Pero, S., Ashikaga, T., Fuller, S., Weaver, D. L., Burdette-Radoux, S., & Thomas, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4441 · Cited by 212
Maynard, J., & Georgiou, G. (2000) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.2.1.339 · Cited by 206
Graff, C. P., & Wittrup, K. D. (2003) · PubMed · Cited by 205
Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS
James, N. D., Coker, R. J., Tomlinson, D., Harris, J. R. W., Gompels, M., Pinching, A. J., & Stewart, J. S. W. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80269-9 · Cited by 205
Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies
Aronov, O., Horowitz, A. T., Gabizon, A., & Gibson, D. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025642l · Cited by 198
Guzman, L. A., Labhasetwar, V., Song, C., Jang, Y., Lincoff, A. M., Levy, R., & Topol, E. J. (1996) · Circulation · doi:10.1161/01.cir.94.6.1441 · Cited by 177
Nielsen, U. B., Kirpotin, D. B., Pickering, E. M., Hong, K., Park, J. W., Refaat Shalaby, M., Shao, Y., Benz, C. C., & Marks, J. D. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00256-2 · Cited by 177
Furgeson, D. Y., Dreher, M. R., & Chilkoti, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.006 · Cited by 175
Targeting tumor angiogenic vasculature using polymer–RGD conjugates
Mitra, A., Mulholland, J., Nan, A., McNeill, E., Ghandehari, H., & Line, B. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.023 · Cited by 162
Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation
Reddy, J. A., & Low, P. S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00135-2 · Cited by 155
McWhirter, J. R., Kretz-Rommel, A., Saven, A., Maruyama, T., Potter, K. N., Mockridge, C. I., Ravey, E. P., Qin, F., & Bowdish, K. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510081103 · Cited by 154
Holland, T. A., & Mikos, A. G. (2006) · Springer eBooks · doi:10.1007/b137205 · Cited by 146
Chiu, S.-J., Ueno, N. T., & Lee, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.019 · Cited by 146
Ohannesian, D. W., Lotan, D., Thomas, P., Jessup, J. M., Fukuda, M., Gabius, H., & Lotan, R. (1995) · PubMed · Cited by 144
Schröder, U., & Sabel, B. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01375-x · Cited by 141
Shmeeda, H., Mak, L., Tzemach, D., Astrahan, P., Tarshish, M., & Gabizon, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0543 · Cited by 137
In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging
Kelly, K. A., Nahrendorf, M., Yu, A. M., Reynolds, F., & Weissleder, R. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0043-6 · Cited by 136
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
Fassas, Α., & Anagnostopoulos, Α. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500052438 · Cited by 134
Xiong, X.-B., Huang, Y., Lü, W.-L., Zhang, X., Zhang, H., Nagai, T., & Zhang, Q. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20397 · Cited by 134
Bibby, D. C., Talmadge, J. E., Dalal, M. K., Kurz, S. G., Chytil, K. M., Barry, S. E., Shand, D. G., & Steiert, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.021 · Cited by 133
Turk, M. J., Reddy, J. A., Chmielewski, J. A., & Low, P. S. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00441-2 · Cited by 123
Matsusue, Y., Hanafusa, S., Yamamuro, T., Shikinami, Y., & Ikada, Y. (1995) · PubMed · Cited by 122
Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues.
Clauss, M. A., & Jain, R. K. (1990) · PubMed · Cited by 110
In Vivo Selection of Phage for the Optical Imaging of PC-3 Human Prostate Carcinoma in Mice
Newton, J. R., Kelly, K. A., Mahmood, U., Weissleder, R., & Deutscher, S. L. (2006) · Neoplasia · doi:10.1593/neo.06331 · Cited by 110
Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles
Arias, J. L., Gallardo, V., Linares-Molinero, F., & Delgado, Á. V. (2006) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2006.03.005 · Cited by 109
Chiu, S.-J., Liu, S., Perrotti, D., Marcucci, G., & Lee, R. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.011 · Cited by 108
Larina, I. V., Evers, B. M., Ashitkov, T. V., Bartels, C., Larin, K. V., & Esenaliev, R. O. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400211 · Cited by 91
New approaches to antibody therapy
Weiner, L. M., & Adams, G. P. (2000) · Oncogene · doi:10.1038/sj.onc.1204000 · Cited by 88
Hansson, M., Ringdahl, J., Robert, A., Power, U. F., Goetsch, L., Nguyen, T. N., Uhlén, M., Ståhl, S., & Nygren, P. (1999) · Immunotechnology · doi:10.1016/s1380-2933(98)00026-8 · Cited by 85
Beekman, K. W., Colevas, A. D., Cooney, K. A., DiPaola, R. S., Dunn, R. L., Gross, M. E., Keller, E. T., Pienta, K. J., Ryan, C. J., Smith, D. C., et al. (2006) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2006.n.012 · Cited by 80
RNA interference and human disease
Cheng, J. C., Moore, T. B., & Sakamoto, K. M. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.011 · Cited by 79
Zubieta, M. R., Furman, D., Barrio, M. M., Bravo, A., Domenichini, E., & Mordoh, J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050971 · Cited by 76
Moghimi, S. M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699130 · Cited by 76
Targeting Cancer Cells with Dendrimers
Sampathkumar, S., & Yarema, K. J. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.12.007 · Cited by 70
Eerikäinen, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00370-3 · Cited by 70
Targeted and sustained drug delivery using PEGylated galactosylated liposomes
Managit, C., Kawakami, S., Nishikawa, M., Yamashita, F., & Hashida, M. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00383-1 · Cited by 68
LIPOSOMAL DAUNORUBICIN OVERCOMES DRUG RESISTANCE IN HUMAN BREAST, OVARIAN AND LUNG CARCINOMA CELLS
Sadava, D., Coleman, A., & Kane, S. E. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120016196 · Cited by 63
Characterization of Glucose-Mediated Insulin Release from Implantable Polymers
Brown, L. R., Edelman, E. R., Fischel-Ghodsian, F., & Langer, R. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9600686 · Cited by 58
Self-citationRadioimmunotherapy for B-cell non-Hodgkin lymphoma
Witzig, T. E. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.05.002 · Cited by 57
Identification of cancer targets and therapeutics using phage display.
Brissette, R. E., Prendergast, J. K. A., & Goldstein, N. I. (2006) · PubMed · Cited by 53
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Ellerhorst, J. A., Bedikian, A. Y., Ring, S. E., Buzaid, A. C., Eton, O. E., & Legha, S. S. (1999) · Oncology Reports · doi:10.3892/or.6.5.1097 · Cited by 49
Wolf, P., Gierschner, D., Bühler, P., Wetterauer, U., & Elsässer‐Beile, U. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0131-0 · Cited by 49
David, A., Kopečková, P., Kopec̆ek, J., & Rubinstein, A. (2002) · Pharmaceutical Research · doi:10.1023/a:1019885807067 · Cited by 47
Doxorubicin-Conjugated Anti-Midkine Monoclonal Antibody as a Potential Anti-Tumor Drug
Inoh, K., Muramatsu, H., Torii, S., Ikematsu, S., Oda, M., Kumai, H., Sakuma, S., Inui, T., Kimura, T., & Muramatsu, T. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl004 · Cited by 34
Antisense approaches in prostate cancer
Chi, K. N., & Gleave, M. E. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.6.927 · Cited by 27
Radioimmunotherapy for B‐Cell Non‐Hodgkin Lymphoma
Witzig, T. E. (2010) · Wiley eBooks · doi:10.1002/9780470613214.ch6 · Cited by 23
Belimezi, M., Papanastassiou, D., Merkouri, E., Baxevanis, C. N., & Mamalaki, A. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0100-z · Cited by 21
Cited by
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Self-citationCellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Self-citationLipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Mishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Metadata
- Authors
- Alexis, F., Rhee, J.-W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C.
- Venue
- Urologic Oncology: Seminars and Original Investigations
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 26
- Issue
- 1
- Pages
- 74-85
- ISSN
- 1078-1439 (ISSN-L)
- OpenAlex
- W1989220118
- Cited by
- 347
- References
- 141
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.